PO.PS01.10 · 人群科学
西班牙裔乳腺癌幸存者的淋巴水肿症状负担模式与癌症复发担忧:潜在剖面分析
Lymphedema symptom burden patterns and cancer recurrence worry among Hispanic breast cancer survivors: Latent profile analysis
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
背景:乳腺癌幸存者常经历持续的身体和社会心理挑战,包括淋巴水肿症状和未满足的支持性照护需求。既往研究指出,这些负担的同时存在可能会叠加其对心理压力(如复发担忧)的影响。西班牙裔人群可能面临独特的生存挑战,限制其获得医疗保健和支持的机会。
目的:本研究考察了西班牙裔乳腺癌女性中淋巴水肿症状负担和未满足支持需求的潜在剖面,以及这些剖面之间复发担忧的差异。
方法:在2023年9月至2025年10月期间,招募了年龄20岁及以上、既往在佛罗里达州中部确诊乳腺癌的西班牙裔女性参加一项考察健康相关生活质量的人群研究。使用FACT-B+4量表评估五项淋巴水肿症状(疼痛、肿胀、活动、麻木、僵硬)。使用35项癌症幸存者未满足需求问卷评估5个未满足需求领域(信息需求、照护需求、生活质量需求、心理需求和实际需求)的强度。进行潜在剖面分析以识别不同的潜在负担模式,并采用BIC、AIC和熵值评估模型性能。采用多变量线性回归比较所识别剖面之间复发担忧(频率、情绪影响、日常功能干扰)的差异,复发担忧通过3项Lerman乳腺癌担忧量表测量。
结果:共有564例乳腺癌幸存者(平均年龄:58.9 ± 11.9岁;自诊断以来平均时间:4.1 ± 2.0年)纳入潜在剖面分析。五剖面模型被选为最优模型。这五个不同的剖面包括:低症状与中等需求(剖面1:n = 72,12.8%)、高症状与中等需求(剖面2:n = 52,9.2%)、高症状与强烈需求(剖面3:n = 34,6.0%)、低症状与低需求(剖面4:n = 303,53.7%)以及中等症状但低需求(剖面5:n = 103,18.3%)。各剖面在复发担忧频率、情绪影响、日常活动干扰方面差异显著(均p < 0.001)。剖面1、2和3中的幸存者报告的担忧频率更高、对情绪的影响更大、对日常功能的干扰更强,均高于剖面4和5中的幸存者。
结论:不同的负担剖面凸显了西班牙裔乳腺癌女性生存体验的异质性。尤其是具有中等或强烈未满足需求的幸存者报告了较高的复发担忧。研究症状管理的障碍以及应对未满足支持需求的策略,对于减轻乳腺癌幸存者的心理压力和提升其生活质量至关重要。
资助:佛罗里达乳腺癌基金会。
查看英文原文 English abstract
Background: Breast cancer survivors often experience persistent physical and psychosocial challenges, including lymphedema symptoms and unmet supportive care needs. Previous studies have noted that the simultaneous occurring of these burdens may compound their effects on psychological stress, such as recurrence worry. Hispanic populations may face unique survivorship challenges that limit access to healthcare and support.
Objective: This study examined latent profiles of burden from lymphedema symptoms and unmet support needs, and differences in recurrence worry across these profiles within Hispanic women with breast cancer.
Methods: Hispanic women aged 20 and older, previously diagnosed with breast cancer in Central Florida, were for a population-based study examining health-related quality of life from September 2023 to October 2025. Five lymphedema symptoms (pain, swelling, movement, numbness, stiffness) were assessed using the FACT-B+4 scale. The strength of 5 unmet need domains (information needs, care needs, quality of life needs, psychological needs, and practical needs) was assessed using the 35-item Cancer Survivors' Unmet Needs questionnaire. Latent profile analysis was conducted to identify the distinct latent burden patterns, and model performance was evaluated with BIC, AIC, and entropy. Multivariable linear regression compared differences in recurrence worry (frequency, mood impact, daily function interference), measured by the 3-item Lerman Breast Cancer Worry Scale, across the identified profiles.
Results: A total of 564 breast cancer survivors (mean age: 58.9 ± 11.9 years; mean time since diagnosis: 4.1 ± 2.0 years) were included in the latent profile analysis. The five-profile model was selected as the optimal model. The five distinct profiles include low symptoms and moderate needs (Profile 1: n = 72, 12.8%), high symptoms and moderate needs (Profile 2: n = 52, 9.2%), high symptoms and strong needs (Profile 3: n = 34, 6.0%), low symptom and low needs (Profile 4: n = 303, 53.7%), and moderate symptoms but low needs (Profile 5: n = 103, 18.3%). Profiles differed significantly in recurrence worry frequency, mood impact, daily activity interference (all p < 0.001). Survivors in Profiles 1, 2, and 3 reported more frequent worry, higher impact on mood, and higher interference with daily functioning than those in Profiles 4 and 5.
Conclusions: Distinct burden profiles highlight heterogeneity in the survivorship experience of Hispanic women with breast cancer. Particularly, survivors with moderate or strong unmet needs reported elevated recurrence worry. Investigating the barriers to symptom management and the strategies to address unmet support needs is crucial to reducing psychological stress and enhancing the quality of life among breast cancer survivors.
Funding: Florida Breast Cancer Foundation.
利益披露 Disclosure
E. Lee, None..
B. D. Sukhu, None..
J. Park, None..
J. Crook, None..
J. Chung, None..
V. Loerzel, None.